LOS ANGELES--(BUSINESS WIRE)--Canopus BioPharma, Inc. (OTCPK: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York on November 5-7, 2007.